openPR Logo
Press release

CD BioGlyco Launches GalNAc-L96 Platform for Targeted siRNA Delivery to Hepatocytes

07-31-2025 03:36 PM CET | Science & Education

Press release from: ABNewswire

Official CD BioGlyco logo - A biotech pioneer specializing in targeted siRNA/mRNA delivery systems, featuring the proprietary GalNAc-L96 platform

Official CD BioGlyco logo - A biotech pioneer specializing in targeted siRNA/mRNA delivery systems, featuring the proprietary GalNAc-L96 platform

CD BioGlyco launches a novel GalNAc-L96-based nucleic acid delivery system for precise and stable siRNA/mRNA therapies.
CD BioGlyco has rolled out a newly designed nucleic acid drug delivery [https://www.bioglyco.com/nucleic-acid-drug-delivery-products.html] system for siRNA- and mRNA-based therapeutics.

Built around refined glycosylation chemistry, the platform focuses on improving how molecules like siRNA and mRNA are brought into target cells. Rather than tweaking existing methods, the company has opted for a ground-up redesign that reflects recent lab needs-especially in gene-targeted treatments and RNA-based vaccines. In many labs, researchers working with nucleic acid drugs face the same challenges: the molecules degrade too easily, fail to efficiently reach target cells, or exhibit inconsistent performance across tissues. These limitations hinder research progress. CD BioGlyco's new system overcomes these issues by incorporating GalNAc sugar ligands for liver-specific targeting, enabling precise control over drug assembly and release.

The new platform is built around GalNAc-L96 [https://www.bioglyco.com/nucleic-acid-drug-delivery-products.html], CD BioGlyco's proprietary triantennary ligand designed to enhance liver-targeted siRNA delivery. This structure specifically binds the ASGPR receptor on hepatocytes, enabling efficient and selective cellular uptake. By leveraging GalNAc-L96, researchers can achieve modular assembly of oligonucleotide [https://www.bioglyco.com/oligonucleotide-modification-service.html] therapies, allowing for greater flexibility in optimizing drug performance and reducing off-target effects.

While the platform was built with liver-targeted treatments in mind, its modular design means it can be adapted for other uses too. Teams working in cancer biology, infectious disease, and metabolic disorders can use the same core chemistry to deliver payloads into different types of cells. In preclinical collaborations, the system has already shown better uptake and more even response across sample groups-especially in studies involving mRNA vaccines and gene silencing tools. "This wasn't about adding a feature or two," said Anna, a spokesperson for CD Bioglyco. "We kept seeing the same problems show up in nucleic acid drug delivery-especially when researchers moved from cell culture to animal models. So we stepped back and rebuilt the process. What we've got now is something that actually fits the pace and complexity of current RNA-based research." The company is currently working with several academic and biotech groups to refine its system across more cell types and disease areas. For labs looking to test nucleic acid therapies with tighter control and cleaner readouts, CD BioGlyco's new platform is now available for collaboration and pilot projects.

More information about the system and its development pipeline can be found at: https://www.bioglyco.com/nucleic-acid-drug-delivery-products.html

Media Contact
Company Name: CD BioGlyco
Contact Person: Anna Bryan
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioglyco-launches-galnacl96-platform-for-targeted-sirna-delivery-to-hepatocytes]
Country: United States
Website: https://www.bioglyco.com/nucleic-acid-drug-delivery-products.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CD BioGlyco Launches GalNAc-L96 Platform for Targeted siRNA Delivery to Hepatocytes here

News-ID: 4128576 • Views:

More Releases from ABNewswire

Mind Above Matter Expands Access to Mental Health Support with Virtual Group Therapy for Keller, TX
Mind Above Matter Expands Access to Mental Health Support with Virtual Group The …
Mind Above Matter in Keller, TX, is enhancing access to mental health care by offering virtual group therapy sessions. This expansion allows individuals to receive professional support from the comfort of their homes, making mental health services more accessible and convenient for the community. Keller, TX - Dec 19, 2025 - Mind Above Matter, a leading provider of outpatient group treatment services in Keller, TX, is expanding its mental health support
Mahogany Kitchens Discusses the Growing Demand for Custom Cabinetry in Palm Beach County
Mahogany Kitchens Discusses the Growing Demand for Custom Cabinetry in Palm Beac …
Mahogany Kitchens highlights the growing preference for tailored cabinetry in Palm Beach County, covering local trends in kitchen remodeling and handcrafted woodwork solutions. Palm Beach County has seen a notable shift in how homeowners approach interior design, with a growing preference for custom cabinetry that reflects personal style and functional needs. Mahogany Kitchens, a Boynton Beach-based woodwork company, has observed this trend firsthand while serving clients throughout South Florida. The increased
Prince Health Introduces PlaqueX IV Therapy in The Woodlands for Cardiovascular and Metabolic Wellness
12-20-2025 | Sports
ABNewswire
Prince Health Introduces PlaqueX IV Therapy in The Woodlands for Cardiovascular …
Prince Health in The Woodlands, TX, announces the launch of PlaqueX IV therapy, a non-surgical functional medicine treatment designed to support heart health and reduce arterial plaque. Led by Dr. Ashley Prince, DC, the practice offers this advanced phosphatidylcholine infusion to help patients improve circulation and lipid metabolism. This proactive cardiovascular solution is now available to residents in the Greater Houston area. THE WOODLANDS, Texas - December 19, 2025 - Prince
From London Comforts to Vietnamese Chaos: Author Jane Roberts Unveils the Gritty Reality of Chasing a Global Dream
From London Comforts to Vietnamese Chaos: Author Jane Roberts Unveils the Gritty …
When a high-stakes job offer in Hanoi disrupts a settled life in the UK, one woman abandons her safety net to build a market-leading empire amidst humidity, hardship, and the unknown-proving that true transformation only happens when you stop playing it safe. In her powerful debut, Follow Your Dreams: Dare to Venture into the Unknown, Jane Roberts brings us a compelling narrative about the transformative power of chasing your dreams, even

All 5 Releases


More Releases for BioGlyco

Glycosphingolipid Market Top Companies Study - CD BioGlyco, CarboCode Germany Gm …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Glycosphingolipid Market- (By Type (Neutral and Negatively Charged), By Application (Medical, Chemical and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Glycosphingolipid Market is expected to expand with a CAGR of 4.68% during the forecast period of 2024-2031. Get Free Access to Demo
Empowering Growth: Glycomics Profiling Services Market 2024 and Industry Segment …
A new Report by Worldwide Market Reports, titled "Glycomics Profiling Services Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Glycomics Profiling Services market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Glycomics
Factors Influencing Global Complex Carbohydrate Profiling Services Market throug …
The worldwide "Complex Carbohydrate Profiling Services Market" 2023 Research Report presents a professional and complete analysis of the Global Complex Carbohydrate Profiling Services Market in the current situation. This report includes development plans and policies along with Complex Carbohydrate Profiling Services manufacturing processes and price structures. the reports 2023 research report offers an analytical view of the industry by studying different factors like Complex Carbohydrate Profiling Services Market growth, consumption
Complex Carbohydrate Insights: Glycan Profiling Services Shaping Research | Chem …
Glycan Profiling Services Market 2023 Forecast: Unveiling Opportunities and Growth Glycan Profiling Services market report presents an overview of the market on the basis of key parameters such as market size, revenue, sales analysis and key drivers. The market size of global Glycan Profiling Services market is anticipated to grow at large scale over the forecast period (2023-2029). The main purpose of the study report is to give users an extensive
Top Key Players and Factors Driving Glycan Profiling Services Market Growth for …
Glycan Profiling Services Market Report Study WMR has announced the addition of Glycan Profiling Services Market 2023 Forecast Analysis by Types, Applications, Size, Share, Key Players, and Regions. a new research report to its market research archive. The Glycan Profiling Services Market has been thoroughly researched and analysed by industry experts and researchers. The industry is examined at the global, regional, and national levels. The report highlights the primary revenue stream
CD BioGlyco Introduces Custom Glycosylation Services of Proteins
CD BioGlyco, a leader in the field of glycan remodeling, released custom glycosylation services of proteins for its global customers based on biochemistry and organic chemistry. Glycosylation is the process of adding glycans to proteins or lipids under the control of enzymes and occurs in the endoplasmic reticulum and Golgi apparatus. It transfers glycans to proteins under the action of glycosyltransferases and covalently binds to amino acid residues on proteins. Proteins